📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: TScan

1.1 - Company Overview

TScan Logo

TScan

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of TCR-T immunotherapies and platforms for cancer, including TSC-100 and TSC-101 targeting minor histocompatibility antigens HA-1 and HA-2 for post-transplant hematologic malignancies. Offers ImmunoBank of therapeutic TCRs for multiplexed solid tumor therapies, plus TargetScan, ReceptorScan, SafetyScan, and T-Integrate for target discovery, safety screening, and non-viral manufacturing.

Products and services

  • ImmunoBank: A multiplexed repository of therapeutic TCRs that offers development of TCR-T products for solid tumors by aggregating banked receptors to architect multiplexed cell therapies
  • T-Integrate: A non-viral manufacturing platform for TCR-T therapies that enables multiplexing and T cell enhancements, delivering build processes to produce enhanced therapeutic TCR assemblies
  • TSC-100 and TSC-101: TCR-T therapies targeting minor histocompatibility antigens HA-1 and HA-2 for hematologic malignancies post-transplant, producing targeted recognition of HA-1/HA-2 in post-transplant patients

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to TScan

Universal Cells Logo

Universal Cells

HQ: United States Website
  • Description: Provider of nuclease-free rAAV gene editing technology to create universal donor pluripotent and engineered allogeneic stem cells, and cell production for clinical trials. Develops, licenses and commercializes stem cell therapies designed to overcome immune rejection and enable true off-the-shelf therapeutic products using a proprietary genome editing approach.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Universal Cells company profile →
CytoSen Logo

CytoSen

HQ: United States Website
  • Description: Provider of natural killer (NK) cell therapeutics focused on advancing effective, expedient, and accessible NK cell therapy to fight cancer for patients and providers across a wide range of points of care.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CytoSen company profile →
Angioblast Logo

Angioblast

HQ: United States Website
  • Description: Provider of biotechnology therapeutic products targeting cardiovascular diseases, developing and commercializing adult stem cell therapies, protein therapeutics, gene silencing solutions, small molecule peptides and antibodies, cytokines and antigen-receptor inhibitors, DNAzymes, and MPC.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Angioblast company profile →
Histogenics Logo

Histogenics

HQ: United States Website
  • Description: Provider of tissue regeneration treatments for long-lasting joint repair.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Histogenics company profile →
Orthofix Logo

Orthofix

HQ: United States Website
  • Description: Provider of medical devices and digital solutions for spine procedures (alignment, disc height improvement, nerve decompression, instability correction); biologics including viable-cell allografts, structural allografts, synthetic bone grafts, and amniotic membranes; PEMF bone growth therapy for spinal fusion and nonunion fractures; and the Fitbone motorized intramedullary nail for femur/tibia transport or lengthening.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Orthofix company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for TScan

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to TScan

2.2 - Growth funds investing in similar companies to TScan

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for TScan

4.2 - Public trading comparable groups for TScan

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to TScan

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About TScan

What does TScan do?

TScan is a provider of TCR-T immunotherapies and platforms for cancer, including TSC-100 and TSC-101 targeting minor histocompatibility antigens HA-1 and HA-2 for post-transplant hematologic malignancies. Offers ImmunoBank of therapeutic TCRs for multiplexed solid tumor therapies, plus TargetScan, ReceptorScan, SafetyScan, and T-Integrate for target discovery, safety screening, and non-viral manufacturing.

Who are TScan's competitors?

TScan's competitors and similar companies include Universal Cells, CytoSen, Angioblast, Histogenics, and Orthofix.

Where is TScan headquartered?

TScan is headquartered in United States.

How many employees does TScan have?

TScan has 1,000 employees 🔒.

When was TScan founded?

TScan was founded in 2010 🔒.

What sector and industry vertical is TScan in?

TScan is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for TScan

Who are the top strategic acquirers in TScan's sector and industry

Top strategic M&A buyers and acquirers in TScan's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for TScan?

Top strategic M&A buyers groups and sectors for TScan include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in TScan's sector and industry vertical

Which are the top PE firms investing in TScan's sector and industry vertical?

Top PE firms investing in TScan's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in TScan's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in TScan's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in TScan's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to TScan include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in TScan's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for TScan?

The key public trading comparables and valuation benchmarks for TScan include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for TScan for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for TScan with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in TScan's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for TScan with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in TScan's' sector and industry vertical?

Access recent funding rounds and capital raises in TScan's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for TScan